Vogelsang K, Zirngibl F, Mezger M, Kassa C, Ernst J, Greil J, Maecker-Kolhoff B, Basu O, Schneider P, Jarisch A, Wölfl M, Dalle J-H, Osswald E, Tribanek M, Lazarou-Wild M, Lang P, von Stackelberg A, Bönig H, Bader P. Real-world outcomes of the mesenchymal stromal cell product tomostrocel in heavily pretreated pediatric patients with refractory acute graft-versus-host disease. haematol [Internet]. 2020Sep.10 [cited 2026Aug.15];. Available from: https://haematologica.org/article/view/14349